View Post

Can Melatonin Alleviate Symptoms of Cognitive Impairment in Patients With Breast Cancer?

In Clinical Studies News by Barbara Jacoby

By: Maggie L. Shaw From: ajmc.com Cognitive impairment is a well-documented adverse effect (AE) of treatment from breast cancer, and it can appear soon after treatment begins or far down the road. The rate of occurrence, however, during chemotherapy is more than twice that from before treatment: 52% versus 23%, respectively. Oral melatonin may be of benefit to these patients. …